Caprock Group LLC Purchases New Shares in Liquidia Corporation $LQDA

Caprock Group LLC purchased a new position in Liquidia Corporation (NASDAQ:LQDA) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,632,089 shares of the company’s stock, valued at approximately $37,114,000. Liquidia comprises approximately 0.9% of Caprock Group LLC’s holdings, making the stock its 20th biggest position. Caprock Group LLC owned about 1.88% of Liquidia as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Liquidia by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after acquiring an additional 1,700 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Liquidia by 10.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after purchasing an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Liquidia by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after purchasing an additional 16,022 shares during the period. KLP Kapitalforvaltning AS lifted its stake in Liquidia by 26.9% in the second quarter. KLP Kapitalforvaltning AS now owns 13,200 shares of the company’s stock worth $164,000 after purchasing an additional 2,800 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Liquidia in the second quarter worth about $775,000. Institutional investors own 64.54% of the company’s stock.

Insider Activity

In related news, CFO Michael Kaseta sold 36,932 shares of Liquidia stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $1,382,364.76. Following the transaction, the chief financial officer directly owned 350,919 shares of the company’s stock, valued at $13,134,898.17. This trade represents a 9.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Rajeev Saggar sold 21,142 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $791,345.06. Following the sale, the insider owned 176,883 shares of the company’s stock, valued at approximately $6,620,730.69. This represents a 10.68% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 252,476 shares of company stock valued at $9,173,435. 30.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. BTIG Research reiterated a “buy” rating and issued a $49.00 price target on shares of Liquidia in a report on Friday, January 9th. HC Wainwright upped their price objective on Liquidia from $35.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Wall Street Zen lowered Liquidia from a “buy” rating to a “hold” rating in a research note on Sunday, January 18th. Wells Fargo & Company initiated coverage on shares of Liquidia in a research note on Monday, October 20th. They set an “overweight” rating and a $31.00 target price for the company. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $47.00 price target on shares of Liquidia in a report on Tuesday, November 4th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Sell rating to the stock. According to data from MarketBeat, Liquidia has an average rating of “Moderate Buy” and an average target price of $39.67.

Liquidia Stock Performance

Shares of Liquidia stock opened at $40.54 on Wednesday. The company has a current ratio of 2.20, a quick ratio of 1.96 and a debt-to-equity ratio of 6.19. The stock’s fifty day moving average price is $37.09 and its 200-day moving average price is $29.40. The firm has a market cap of $3.53 billion, a P/E ratio of -28.15, a P/E/G ratio of 1.19 and a beta of 0.46. Liquidia Corporation has a 12 month low of $11.26 and a 12 month high of $46.67.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).